MARIA EASLER

Mrs. MARIA EASLER

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 May 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
BABeatrice Auletta
Beatrice Auletta
LRLucia Rossi
Lucia Rossi
FCFrancesca Cecchinato
Francesca Cecchinato
GBGilda Barbato
Gilda Barbato
ALAgnese Lauroja
Agnese Lauroja
Anna UrciuoloAnna Urciuolo
Anna Urciuolo
Human neuromuscular organoids (NMOs) derived from induced pluripotent stem cells (hiPSCs) hold a great potential to study (dys)functional human skeletal muscle (SkM) in vitro. The three-dimensional (3D) self-assembly of NMOs leads to the generation of spheroids, whose 3D organization cannot be controlled. Indeed, proper development, maturation and function of the innervated SkM require a well-defined multiscale 3D organization of the cells in a tissue-specific extracellular matrix (ECM) context. We hypothesized that extracellular structural imprinting along with hiPSC small-molecule-based differentiation could provide self-assembly guidance driving NMO morphogenesis and promoting the maturation and function of the human neuronal-coupled SkM in vitro models. We found that SkM ECM, provided as decellularized skeletal muscle, is able to reproducibly guide the morphogenesis of differentiating hiPSC toward multiscale structured tissue-like NMOs (t-NMOs). T-NMOs show contractile activity and possess functional neuromuscular junctions (NMJs), with mature neuromuscular system upon 30 days of hiPSC differentiation. We found that t-NMO could mimic altered muscle contraction upon administration of neurotoxins that act at NMJ level. Finally, we used hiPSCs derived from patients affected by Duchenne Muscular Dystrophy (DMD) to produce DMD t-NMOs that, upon neuronal stimulation, were able to mimic the altered SkM contractility and calcium dynamics typical of the disease. Altogether, our data confirm the ability of t-NMO platform to model in vitro human neuromuscular system (patho)physiology.

26 September 2026 in Anesthesia Research
Verified
Journal Article
Open access
PDF file
NUNaeel Uddin
Naeel Uddin
MHMarwa Hamdam
Marwa Hamdam
MEMARIA EASLER
MARIA EASLER
CGChandu Goli
Chandu Goli
AMAyanda Chantelle Mkhize
Ayanda Chantelle Mkhize
KBKyle B. Bills
Kyle B. Bills
Background/Objectives: Safe anesthesia and effective pain management in conflict-affected regions are limited by violence, damaged infrastructure, disrupted supply chains, medication and equipment shortages, and loss of trained personnel. This narrative review examines major barriers to perioperative care and practical strategies that may improve access and safety. Methods: A structured literature search evaluated peer-reviewed studies, global health reports, and humanitarian publications, primarily from January 2015 through September 2025, with older foundational clinical sources included when directly relevant to specific anesthesia techniques. Results: Major barriers included shortages of essential anesthetic medications and trained providers, damaged healthcare infrastructure, limited monitoring and oxygen availability, and disrupted supply chains. Reported strategies included ketamine-based anesthesia, regional anesthesia, portable oxygen and anesthesia technologies, telemedicine, and task-sharing models supported by training and local health-system capacity. Obstetric, neonatal, and pediatric patients may face additional risks when appropriately sized equipment, blood products, monitoring, and specialist support are limited. Conclusions: Improving anesthesia and pain management in conflict settings requires adaptable clinical strategies, workforce training, reliable access to essential medications and equipment, and partnerships that strengthen local capacity. Evidence remains heterogeneous, and more conflict-specific outcome data are needed.